Epidemiology of extended spectrum beta-lactamases (ESBL) Enterobacteriaceae in a General Hospital, South of France, 1999-2007

被引:8
作者
Anastay, M. [1 ]
Lagier, E. [2 ]
Blanc, V. [1 ]
Chardon, H. [2 ]
机构
[1] Ctr Hosp Paix Aix, F-13616 Aix En Provence 1, France
[2] Ctr Hosp Antibes Juan les Pins, F-06606 Antibes, France
来源
PATHOLOGIE BIOLOGIE | 2013年 / 61卷 / 02期
关键词
Extended spectrum beta-lactamase; Epidemiology; Escherichia coli; CTX-M; CTX-M-TYPE; MOLECULAR EPIDEMIOLOGY; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; DISSEMINATION; PREVALENCE; NATIONWIDE; EMERGENCE; STRAINS; SPREAD;
D O I
10.1016/j.patbio.2012.03.001
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Purpose of the study. - The global epidemiology of extended spectrum betalactamases (ESBL) producing Enterobacteriaceae has evolved in recent years with the emergence of a new type of ESBL: CTX-M, mainly in Escherichia coli. These CTX-M type producing Enterobacteriaceae are responsible for both nosocomial and, more recently, community infections, including urinary tract infections. The aim of our work is to study ESBL producing Enterobacteriaceae evolution between 1999 and 2007 in the population from the Centre Hospitaller du Pays-d'Aix (CHPA), a general hospital from South of France. Patients and methods. - ESBL producing strains of Enterobacteriaceae isolated in odd years between 1999 and 2007 from clinical isolates of all origins have been phenotypically identified and their ESBL genotyped. Molecular and epidemiological data from our hospital health-care associated infection committee were analyzed. Results. - Two hundred and sixty-two ESBL producing isolates were studied. Within ESBL producing Enterobacteriaceae, Enterobacter aerogenes was predominant in 1999 (48.7% of isolates), and decreased to 18.8% of isolates in 2007. On the other hand, E. coli, which represented 10.5% of ESBL isolates in 1999,. grew up to 37.5% of the isolates in 2007. ESBL prevalence in E. coli increased during this period from 0.3 to 2.5%. Simultaneously, ESBL, predominantly TEM-24 in 1999, were replaced by CTX-M in 2007, among which CTX-M-15 is predominant (88% of CTX-M). Conclusion. - Our study confirms a major change in ESBL epidemiology in CHPA, with the emergence of CTX-M type ESBL, mainly CTX-M 15, and an increase of ESBL prevalence in E. coli. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 26 条
[1]   Nationwide survey of extended-spectrum β-lactamase-producing Enterobacteriaceae in the French community setting [J].
Arpin, C. ;
Quentin, C. ;
Grobost, F. ;
Cambau, E. ;
Robert, J. ;
Dubois, V. ;
Coulange, L. ;
Andre, C. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) :1205-1214
[2]   Extended-spectrum-β-lactamase-producing Enterobacteriaceae strains in various types of private health care centers [J].
Arpin, Corinne ;
Coulange, Laure ;
Dubois, Veronique ;
Andre, Catherine ;
Fischer, Isabelle ;
Fourmaux, Sophie ;
Grobost, Frederic ;
Jullin, Jacqueline ;
Dutilh, Brigitte ;
Couture, Jean-Francois ;
Noury, Patrick ;
Lagrange, Isabelle ;
Ducastaing, Aline ;
Doermann, Henri-Pierre ;
Quentin, Claudine .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (09) :3440-3444
[3]   blaCTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003 [J].
Batchelor, M ;
Hopkins, K ;
Threlfall, EJ ;
Clifton-Hadley, FA ;
Stallwood, AD ;
Davies, RH ;
Liebana, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) :1319-1322
[4]   A NEW PLASMIDIC CEFOTAXIMASE IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI [J].
BAUERNFEIND, A ;
GRIMM, H ;
SCHWEIGHART, S .
INFECTION, 1990, 18 (05) :294-298
[5]   Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].
Bonnet, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14
[6]   Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe [J].
Canton, R. ;
Novais, A. ;
Valverde, A. ;
Machado, E. ;
Peixe, L. ;
Baquero, F. ;
Coque, T. M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 :144-153
[7]   TEM derivative-producing Enterobacter aerogenes strains:: Dissemination of a prevalent clone [J].
Dumarche, P ;
De Champs, C ;
Sirot, D ;
Chanal, C ;
Bonnet, R ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) :1128-1131
[8]   Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France [J].
Eckert, C ;
Gautier, V ;
Saladin-Allard, M ;
Hidri, N ;
Verdet, C ;
Ould-Hocine, Z ;
Barnaud, G ;
Delisle, F ;
Rossier, A ;
Lambert, T ;
Philippon, A ;
Arlet, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1249-1255
[9]   Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-β-lactamase-producing Enterobacteriaceae in France [J].
Galas, Muriel ;
Decousser, Jean-Winoc ;
Breton, Nelly ;
Godard, Thierry ;
Allouch, Pierre Yves ;
Pina, Patrick .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) :786-789
[10]  
JARLIER V, 2004, B EPIDEMIOL HEBDO, V32, P148